Health-related quality of life assessment in health economic analyses involving type 2 diabetes.

Autor: Smith H; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia., James S; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.; School of Health, University of the Sunshine Coast, Petrie, Queensland, Australia.; School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Brown F; Melbourne Diabetes Education and Support, Heidelberg Heights, Victoria, Australia., Gaca M; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.; Australian Centre for Accelerating Diabetes Innovations (ACADI), Department of Medicine, University of Melbourne, Parkville, Victoria, Australia., O'Neal D; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.; Australian Centre for Accelerating Diabetes Innovations (ACADI), Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.; Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia., Tran-Duy A; Australian Centre for Accelerating Diabetes Innovations (ACADI), Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia.; Methods and Implementation Support for Clinical and Health research (MISCH) Hub, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia., Devlin N; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia., Kelly R; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.; Australian Centre for Accelerating Diabetes Innovations (ACADI), Department of Medicine, University of Melbourne, Parkville, Victoria, Australia., Ekinci EI; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.; Australian Centre for Accelerating Diabetes Innovations (ACADI), Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.; Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia.
Jazyk: angličtina
Zdroj: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 Oct; Vol. 41 (10), pp. e15418. Date of Electronic Publication: 2024 Aug 07.
DOI: 10.1111/dme.15418
Abstrakt: Aim: Incorporating health-related quality of life (HRQoL) measures into health economic analyses can help to provide evidence to inform decisions about how to improve patient outcomes in the most cost-effective manner. The aim of this narrative review was to assess which HRQoL instruments have been used in economic evaluations of type 2 diabetes management including in Indigenous communities.
Method: MEDLINE (Ovid), Embase (Ovid) and Cochrane were searched from inception to June 2022. Studies included patients with type 2 diabetes; economic evaluations, derived scores from direct questioning of individuals; and were in English. Records were assessed for bias using the JBI critical appraisal tools.
Results: A total of 3737 records were identified, with 22 publications meeting the criteria for inclusion. Across those 22 articles, nine HRQoL instruments had been utilised. Generic tools were most frequently used to measure HRQoL, including EQ-5D (-3 L and -5 L) (n = 10, 38%); SF-12 (n = 5, 19%); and SF-36 (n = 4, 15%). Two tools addressing the specific stressors faced by people with type 2 diabetes were utilised: Problem Areas In Diabetes tool (n = 1, 4%) and Diabetes Distress Scale (n = 1, 4%). Two publications reported whether the study population included Indigenous peoples.
Conclusion: A wide range of HRQoL instruments are used in economic evaluations of type 2 diabetes management, with the most frequent being varying forms of the EQ-5D. Few economic evaluations noted whether Indigenous peoples were featured in the study population. More research into HRQoL in people living with type 2 diabetes is urgently needed to improve evidence on effectiveness and cost-effectiveness of interventions.
(© 2024 The Author(s). Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.)
Databáze: MEDLINE
Externí odkaz: